Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel boron-catalyzed method for meta-cyano pyridines. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101709323B reveals a novel biocatalytic coupling method for R-mandelic acid production, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN1169418A details a novel Lewis acid-catalyzed condensation for polyene esters, offering superior gamma-selectivity and cost reduction in carotenoid manufacturing compared to Wittig reactions.
Patent CN117185989A reveals light-induced palladium catalysis for high-purity heterocyclic intermediates, offering significant cost reduction and supply chain reliability.
Patent CN116199591A reveals high-purity levocarnitine synthesis via whole-cell catalysis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN117210431A reveals thermostable transaminase mutant for high-purity L-glufosinate. Achieves cost reduction in agrochemical manufacturing and supply reliability.
Advanced enzymatic deracemization of L-glufosinate-ammonium via patent CN112410383B. Delivers superior purity and cost efficiency for global agrochemical supply chains.
Patent CN108137637B reveals a novel ruthenium complex production method with superior atom efficiency, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN118125897A reveals a room-temperature visible-light method for Z-selective monofluoroolefin synthesis, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN112047865B details a green aqueous synthesis of N-alkylsulfonamides using Cp*Ir catalysts, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN116003407A reveals a scalable Zolpidem synthesis using PBr3-Lewis Acid catalysis, offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Novel Ni-catalyzed alpha-butenylation of ketones with 1,3-butadiene. High yield, atom-economic route for API intermediates. Cost-effective supply chain solution.
Patent CN109797174B reveals high-yield ketoreductase route. Reduces heavy metal waste, ensures 100% ee. Ideal for veterinary API supply chains.
Novel MOF catalyst process improves purity and yield for cefquinome sulfate. Reduces toxic solvents and simplifies supply chain for veterinary pharmaceutical manufacturing partners globally.
Patent CN104031050A reveals high ee synthesis. Offers cost reduction and supply reliability for pharma intermediates manufacturing.
Patent CN113004236B reveals a green POMs-catalyzed route for 3-methylenebenzofuran-1(3H)-ones, offering high yields and reduced costs for API manufacturing.
Patent CN114773309A details a high-yield synthesis of Hepatitis C intermediates using Lewis acid catalysis, offering significant cost reduction and supply chain reliability for API manufacturers.
Improved process for 1,2-indane carboxylic acids via chiral auxiliaries. Enhances yield and scalability for pharmaceutical intermediate manufacturing.
Patent CN103102304B reveals efficient trifluorosulfonate catalysis for high-purity pharmaceutical intermediates with reduced steps and scalable yield for global supply.
Novel enzymatic synthesis of ritodrine hydrochloride ensures high purity and cost efficiency for pharmaceutical supply chains globally seeking reliable manufacturing partners.